InvestorsHub Logo
Followers 32
Posts 2200
Boards Moderated 0
Alias Born 09/01/2020

Re: 10baggerz post# 608133

Monday, 07/10/2023 2:46:01 AM

Monday, July 10, 2023 2:46:01 AM

Post# of 701066
That’s what everyone said of the high impact publication (JAMA) 12-18 months before its publication as to how that was going to be a game changer. The same hype was created around specials manufacturing approvals in Dec 2021 and then MIA in March 2023. The reality is Dr. Ashkan and his team at KCL is the only group handling specials patients.

AF and shorts will not stop at UK approval. And given the rich history it’s highly likely NWBO management will be lame ducks again. They have not been able to defend or control the narrative and build shareholder value.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News